Cargando…
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice
B-cell activating factor (BAFF) is regarded as a new therapeutic target in autoimmune diseases such as systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Along with other researchers, we have demonstrated that BAFF inhibitor atacicept (TACI-IgG) suppresses lupus and experimental allergi...
Autores principales: | Wang, Xiaoqian, Xiao, He, Wei, Yinxiang, Liu, Xiaoling, Han, Gencheng, Chen, Guojiang, Hou, Chunmei, Shen, Beifen, Li, Yan, Wang, Renxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637387/ https://www.ncbi.nlm.nih.gov/pubmed/26557026 http://dx.doi.org/10.5114/ceji.2015.52826 |
Ejemplares similares
-
C5a Regulates IL-12(+)DC Migration to Induce Pathogenic Th1 and Th17 Cells in Sepsis
por: Ma, Ning, et al.
Publicado: (2013) -
B cells regulate thymic CD8(+)T cell differentiation in lupus-prone mice
por: Xing, Chen, et al.
Publicado: (2017) -
The E3 ubiquitin ligase Itch is required for B-cell development
por: Liu, Xiaoling, et al.
Publicado: (2019) -
CD19 regulates ADAM28‐mediated Notch2 cleavage to control the differentiation of marginal zone precursors to MZ B cells
por: Zhang, Yu, et al.
Publicado: (2017) -
Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
por: Chen, Guojiang, et al.
Publicado: (2009)